CClinicalTrials.gg
RecruitingNCT06469580Updated Jun 21, 2024

Neonatologist-performed Lung Ultrasound (NPLUS) to Guide Respiratory Therapy to Prevent Extubation Failure

An interventional study of NPLUS (neonatologist performed lung ultrasound) in Neonatal Disease, sponsored by Medical University of Graz. Recruiting at 1 site in Austria. Open to participants aged 1 Minute to 6 Months. Per ClinicalTrials.gov, last updated 2024-06-21.

Sponsored by Medical University of Graz · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
1 Minute to 6 Months
Sex
All
01

Study summary

The objective of the study is to evaluate the role of neonatologist-performed lung ultrasound (NPLUS) after weaning from invasive mechanical ventilation and extubation. Our aim is to study the diagnostic accuracy of NPLUS and investigate whether LUS leads to earlier actions before clinical deterioration and hence prevents extubation failure.

Read the detailed description

In the past few years, lung ultrasound has been established as a tool to dynamically assess the lungs in various clinical conditions. Standardized protocols have been compiled to allow for an easy and fast evaluation. The point-of-care ultrasound (POCUS) is easily accessible and allows the clinician a readily available bed-side evaluation.

Although invasive mechanical ventilation displays a lifesaving strategy in neonatal intensive care, it is associated with numerous long-term complications especially in preterm infants. Despite a shift to lung-protective ventilation, time on mechanical ventilatory support should be kept as short as possible, considering timely weaning and switch to a non-invasive ventilation. Estimating the right time for discontinuation of invasive mechanical ventilation remains challenging and is influenced by several parameters. Extubation failure can be associated with respiratory failure following exhaustion on non-invasive ventilatory support.

Collapse of alveolar units lead to hypo-aerated areas. Small airway size, obstruction due to secretion and muscular weakness predispose to the development of atelectasis in neonates. Atelectasis occurring post extubation are a frequent cause of extubation failure. Lung consolidations can be sonographically detected. A sensitivity of 100% for the detection of neonatal pulmonary atelectasis has been described. In recent studies Lung Ultrasound Severity Score (LUSS) has been shown to be an independent predictor of successful extubation in mechanically ventilated preterm infants. However, once extubated, only limited data is available if extubation failure later in the process can be predicted. Lung aeration decreased after extubation to spontaneous breathing.

Early standardized evaluation of the lung via lung ultrasound can deliver important information on aeration of the lungs and whether action may be required. Using a standardized protocol (lung ultrasound score, LUS) on certain timepoints after extubation can lead to early detection of loss of aeration. Timely intervention with e.g., temporary PEEP increase for alveolar recruitment on non-invasive ventilatory support, positioning of the patient prior to clinical deterioration can impede the need of a reintubation and invasive mechanical ventilatory support.

02

Conditions studied

  • Neonatal Disease

Keywords

  • neonatologist performed lung ultrasound
  • extubation failure
  • neonates
  • consolidation
03

In context

Infant, Newborn, Diseases

134 studies on the registry are indexed under Infant, Newborn, Diseases; 30 are open to participants now.

This study's planned enrollment of 40 is below the median of 72 across 81 interventional studies indexed under Infant, Newborn, Diseases.

Browse Infant, Newborn, Diseases studies →

Lead sponsor

Medical University of Graz is the lead sponsor of 459 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Minute to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All preterm and full-term neonates receiving invasive mechanical ventilation at the Division of Neonatology of the Medical University of Graz AND
  • Written informed consent was obtained from parents prior to extubation

Exclusion criteria

Exclusion Criteria:

none

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    NPLUS group

    In the NPLUS group (intervention group) lung ultrasound is performed at time point T0 (prior to extubation), T1 (2-4 hours post extubation) and time point T2 (16-24 h) post extubation.

    Other: NPLUS (neonatologist performed lung ultrasound)

  • No intervention
    control group

    Includes routine care in the control group in case of clinical (respiratory) deterioration which is optional chest x-ray or NPLUS at any time point after extubation indicated by the clinician in charge. There are no study-specific measures in the control group.

Interventions

  • OtherNPLUS (neonatologist performed lung ultrasound)

    NPLUS is conducted with an ultrasound scanner using a high-frequency (12-15 MHz) linear transducer probe (scanning depth approximately 4-5 cm). The neonate is placed in a supine position. The anterior, lateral and posterior chest areas are scanned using the presets "lung" or "small parts". Landmarks are the anterior and posterior axillary line (longitudinal) on each hemithorax. A sequential scan from right to left, anterior to posterior is performed. (6 lung areas). In the study NPLUS is performed to quantify the lung ultrasound score at time points T0, T1 and T2. Sequences of 3-5 seconds are saved and assessed according to the lung ultrasound score adapted by Rodriguez-Fanjul et al. (0- to 3 point score for each area, resulting in a total score ranging from 0 to 18). To ensure inter-observer reliability the anonymous video sequences are then rated by two independent neonatologists.

06

What researchers measure

Primary outcomes

  1. Reintubation rate (within 72 hours after extubation)

    Time frame: within 72 hours after extubation

Secondary outcomes

  1. Mode of respiratory support

    NCPAP, DUOPAP or BILEVEL during 72 hours after extubation

    Time frame: within 72 hours after extubation

  2. Respiratory settings- FiO2

    FiO2 (fraction of inspired oxygen) during 72 hours after extubation

    Time frame: within 72 hours after extubation

  3. Respiratory settings- PEEP

    PEEP (Positive EndExpiratory Pressure) during 72 hours after extubation

    Time frame: within 72 hours after extubation

  4. SpO2/FiO2 ratio

    Ratio of arterial oxygen saturation and fraction of inspired oxygen

    Time frame: every hour during 72 hours after extubation

  5. pH from capillary blood gas analysis

    pH routinely obtained capillary blood gas analysis at certain time points within 72 hours after extubation

    Time frame: within 72 hours after extubation

  6. Carbon dioxide partial pressure (pCO2)

    pCO2 Routinely obtained capillary blood gas analysis at certain time points within 72 hours after extubation

    Time frame: within 72 hours after extubation

  7. Base Excess (BE)

    BE routinely obtained capillary blood gas analysis at certain time points within 72 hours after extubation

    Time frame: within 72 hours after extubation

  8. Number of lung imaging

    Number of chest X-rays and NPLUS within 72 hours after extubation

    Time frame: within 72 hours after extubation

  9. Number of lung imaging based interventions

    Number and time points of chest X-ray or NPLUS based interventions

    Time frame: within 72 hours after extubation

  10. Recruitment maneuvers

    Number and time points of recruitment maneuvers (PEEP increase, positioning)

    Time frame: within 72 hours after extubation

  11. Time to detect consolidations

    Time to detect impairment of lung aeration (consolidations)

    Time frame: within 72 hours after extubation

  12. Lung ultrasound scores (LUS)

    LUS at time point T0 (prior to extubation), T1 (2-4 hours post extubation) and time point T2 (16-24 h post extubation)

    Time frame: up to 24 hours after extubation

07

Study locations

1 of 1 sites recruiting
  • Department of Pediatrics, Division of Neonatology, Medical University of Graz
    Graz, Styria 8036, Austria
    • Viktoria Gruber, MD · Contact · vi.gruber@medunigraz.at
    • Bernhard Schwaberger, MD · Contact · bernhard.schwaberger@medunigraz.at · 004331638530018
    • Bernhard Schwaberger, MD PhD · Principal investigator
    • Viktoria Gruber, MD · Sub investigator
    • Nariae Baik-Schneditz, MD PhD · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06469580
Lead sponsor
Medical University of Graz
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Jun 1, 2024
Primary completion
May 2025 (estimated)
Completion
May 2025 (estimated)
Last update
Jun 21, 2024

Study contacts

Bernhard Schwaberger, MD PhD
Contact
bernhard.schwaberger@medunigraz.at
+4331638530018
Bernhard Schwaberger, MD PhD
principal investigator · Division of Neonatology, Medical University of Graz, Austria

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion